This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2011 Jan 13;364(2):170-1.

doi: 10.1056/NEJMe1012520.

HDL and cardiovascular-disease risk--time for a new approach?

PMID: 21226584
DOI: 10.1056/NEJMe1012520

Editorial

HDL and cardiovascular-disease risk--time for a new approach?

Jay Heinecke. N Engl J Med. 2011.

. 2011 Jan 13;364(2):170-1.

doi: 10.1056/NEJMe1012520.

Author

PMID: 21226584
DOI: 10.1056/NEJMe1012520

No abstract available

PubMed Disclaimer

Comment in

Cholesterol efflux capacity and atherosclerosis.
Asleh R, Levy AP, Blum S. Asleh R, et al. N Engl J Med. 2011 Apr 14;364(15):1473; author reply 1474-5. doi: 10.1056/NEJMc1101853. N Engl J Med. 2011. PMID: 21488782 No abstract available.

Comment on

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.
Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF, Jafri K, French BC, Phillips JA, Mucksavage ML, Wilensky RL, Mohler ER, Rothblat GH, Rader DJ. Khera AV, et al. N Engl J Med. 2011 Jan 13;364(2):127-35. doi: 10.1056/NEJMoa1001689. N Engl J Med. 2011. PMID: 21226578 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

R01 HL086798/HL/NHLBI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information